{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:54:39Z","timestamp":1787698479137,"version":"build-2784847793"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA015462"],"award-info":[{"award-number":["R01 DA015462"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00213-024-06549-1","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T03:02:33Z","timestamp":1707361353000},"page":"1151-1160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Relationship between opioid cross-tolerance during buprenorphine stabilization and return to opioid use during buprenorphine dose tapering"],"prefix":"10.1007","volume":"241","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9541-7321","authenticated-orcid":false,"given":"Mark K.","family":"Greenwald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolani","family":"Sogbesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabitha E.H.","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"key":"6549_CR1","doi-asserted-by":"publisher","first-page":"937126","DOI":"10.3389\/fnsys.2022.937126","volume":"16","author":"S Adhikary","year":"2022","unstructured":"Adhikary S, Williams JT (2022) Cellular tolerance induced by chronic opioids in the central nervous system. Front Syst Neurosci 16:937126","journal-title":"Front Syst Neurosci"},{"key":"6549_CR2","volume-title":"Diagnostic and statistical Manual of Mental disorders","author":"American Psychiatric Association","year":"2015","unstructured":"American Psychiatric Association (2015) Diagnostic and statistical Manual of Mental disorders, 5th edn. American Psychiatric Association, Washington, DC","edition":"5"},{"key":"6549_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.coph.2004.08.012","volume":"5","author":"CP Bailey","year":"2005","unstructured":"Bailey CP, Connor M (2005) Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 5:60\u201368","journal-title":"Curr Opin Pharmacol"},{"key":"6549_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/17425255.2020.1721458","volume":"16","author":"R Balyan","year":"2020","unstructured":"Balyan R, Hahn D, Huang H, Chidambaran V (2020) Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic. Expert Opin Drug Metab Toxicol 16:125\u2013141","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"6549_CR5","first-page":"96","volume":"20","author":"A Bechara","year":"2019","unstructured":"Bechara A, Berridge KC, Bickel WK, Mor\u00f3n JA, Williams SB, Stein JS (2019) A neurobehavioral approach to addiction: implications for the opioid epidemic and the psychology of addiction. Psychol Sci 20:96\u2013127","journal-title":"Psychol Sci"},{"key":"6549_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.coph.2008.12.014","volume":"9","author":"KC Berridge","year":"2009","unstructured":"Berridge KC, Robinson TE, Aldridge JW (2009) Dissecting components of reward: \u2018liking\u2019, \u2018wanting\u2019 and learning. Curr Opin Pharmacol 9:65\u201373","journal-title":"Curr Opin Pharmacol"},{"key":"6549_CR7","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/add.13339","volume":"111","author":"KS Betts","year":"2016","unstructured":"Betts KS, Chan G, McIlwraith F, Dietze P, Whittaker E, Burns L, Alati R (2016) Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies. Addiction 111:1214\u20131223","journal-title":"Addiction"},{"key":"6549_CR8","unstructured":"Bhatnagar M, Pruskowski J (2023) Opioid equivalency. StatPearls [Internet]. Accessed 8\/22\/23 at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535402\/"},{"key":"6549_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0376-8716(98)00103-3","volume":"53","author":"MJ Carpenter","year":"1998","unstructured":"Carpenter MJ, Chutuape MA, Stitzer ML (1998) Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples. Drug Alcohol Depend 53:11\u201315","journal-title":"Drug Alcohol Depend"},{"key":"6549_CR10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1360-0443.2007.02118.x","volume":"103","author":"KR Connor","year":"2008","unstructured":"Connor KR, Pinquart M, Duberstein PR (2008) Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs). Addiction 103:524\u2013534","journal-title":"Addiction"},{"key":"6549_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/095952304100017044163","volume":"23","author":"S Darke","year":"2004","unstructured":"Darke S, Hetherington K, Ross J, Lynskey M, Teesson M (2004) Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence. Drug Alcohol Rev 23:177\u2013183","journal-title":"Drug Alcohol Rev"},{"key":"6549_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/09595230500102657","volume":"24","author":"S Darke","year":"2005","unstructured":"Darke S, Ross J, Teesson M (2005) Twelve-month outcomes for heroin dependence treatments: does route of administration matter? Drug Alcohol Rev 24:165\u2013171","journal-title":"Drug Alcohol Rev"},{"key":"6549_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0376-8716(96)01290-2","volume":"43","author":"SH Dinwiddie","year":"1996","unstructured":"Dinwiddie SH, Cottler L, Compton W, Abdallah AB (1996) Psychopathology and HIV risk behaviors among injection drug users in and out of treatment. Drug Alcohol Depend 43:1\u201311","journal-title":"Drug Alcohol Depend"},{"key":"6549_CR14","volume-title":"Structured clinical interview for DSM\u2013IV Axis disorders\u2014Patient Edition (SCID-I\/P, Version 2.0)","author":"MB First","year":"1996","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured clinical interview for DSM\u2013IV Axis disorders\u2014Patient Edition (SCID-I\/P, Version 2.0). New York State Psychiatric Institute, Biometrics Research Department, New York"},{"key":"6549_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000094425","volume":"12","author":"B Fischer","year":"2006","unstructured":"Fischer B, Manzoni P, Rehm J (2006) Comparing injecting and non-injecting illicit opioid users in a multisite Canadian sample (OPICAN cohort). Eur Addict Res 12:230\u2013239","journal-title":"Eur Addict Res"},{"key":"6549_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1037\/1064-1297.13.1.3","volume":"13","author":"MK Greenwald","year":"2005","unstructured":"Greenwald MK (2005) Opioid craving and seeking behavior in physically dependent volunteers: effects of acute withdrawal and drug reinforcement opportunity. Exp Clin Psychopharmacol 13:3\u201314","journal-title":"Exp Clin Psychopharmacol"},{"key":"6549_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1901\/jaba.2008.41-603","volume":"41","author":"MK Greenwald","year":"2008","unstructured":"Greenwald MK (2008) Opioid abstinence reinforcement delays heroin lapse during buprenorphine dose tapering. J Appl Behav Anal 41:603\u2013607","journal-title":"J Appl Behav Anal"},{"key":"6549_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.drugalcdep.2010.03.020","volume":"111","author":"MK Greenwald","year":"2010","unstructured":"Greenwald MK (2010) Effects of experimental unemployment, employment and punishment analogs on opioid seeking and consumption in heroin-dependent volunteers. Drug Alcohol Depend 111:64\u201373","journal-title":"Drug Alcohol Depend"},{"key":"6549_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.drugalcdep.2006.03.007","volume":"85","author":"MK Greenwald","year":"2006","unstructured":"Greenwald MK, Hursh SR (2006) Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of unit price and pre-session drug supply. Drug Alcohol Depend 85:35\u201348","journal-title":"Drug Alcohol Depend"},{"key":"6549_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.drugalcdep.2009.04.006","volume":"104","author":"MK Greenwald","year":"2009","unstructured":"Greenwald MK, Steinmiller CL (2009) Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of alternative reinforcer magnitude and post-session drug supply. Drug Alcohol Depend 104:84\u201393","journal-title":"Drug Alcohol Depend"},{"key":"6549_CR21","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00213-012-2868-9","volume":"225","author":"MK Greenwald","year":"2013","unstructured":"Greenwald MK, Lundahl LH, Steinmiller CL (2013) Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals. Psychopharmacology 225:811\u2013824","journal-title":"Psychopharmacology"},{"key":"6549_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.07.035","volume":"144","author":"MK Greenwald","year":"2014","unstructured":"Greenwald MK, Comer SD, Fiellin DA (2014) Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy. Drug Alcohol Depend 144:1\u201311","journal-title":"Drug Alcohol Depend"},{"key":"6549_CR22","doi-asserted-by":"crossref","unstructured":"Greenwald MK, Moses TEH, Lundahl LH (2023a) Prediction of lifetime heroin overdose: injection use, quit attempts, suicidal ideation, and hepatitis. Oral presentation at the 85th annual meeting of the College on Problems of Drug Dependence, Denver CO","DOI":"10.1016\/j.drugalcdep.2023.110093"},{"key":"6549_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12954-023-00906-7","volume":"20","author":"MK Greenwald","year":"2023","unstructured":"Greenwald MK, Wiest K, Haight B, Laffont CM, Zhao Y (2023b) Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting users treated for opioid use disorder. Harm Reduct J 20:173","journal-title":"Harm Reduct J"},{"key":"6549_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00008877-199302000-00001","volume":"4","author":"RR Griffiths","year":"1993","unstructured":"Griffiths RR, Troisi JR, Silverman K, Mumford GK (1993) Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behav Pharmacol 4:3\u201313","journal-title":"Behav Pharmacol"},{"key":"6549_CR26","doi-asserted-by":"publisher","first-page":"109428","DOI":"10.1016\/j.drugalcdep.2022.109428","volume":"234","author":"EW Hall","year":"2022","unstructured":"Hall EW, Rosenberg ES, Jones CM, Asher A, Valverde E, Bradley H (2022) Estimated number of injection-involved drug overdose deaths, United States, 2000\u20132018. Drug Alcohol Depend 234:109428","journal-title":"Drug Alcohol Depend"},{"key":"6549_CR27","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1111\/j.1360-0443.2007.01998.x","volume":"102","author":"DA Highfield","year":"2007","unstructured":"Highfield DA, Schwartz RP, Jaffe JH, O\u2019Grady KE (2007) Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome. Addiction 102:1816\u20131823","journal-title":"Addiction"},{"key":"6549_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jsat.2012.08.016","volume":"44","author":"M Hillhouse","year":"2013","unstructured":"Hillhouse M, Canamar CP, Ling W (2013) Predictors of outcome after short-term stabilization with buprenorphine. J Subst Abuse Treat 44:336\u2013342","journal-title":"J Subst Abuse Treat"},{"key":"6549_CR29","doi-asserted-by":"publisher","first-page":"103584","DOI":"10.1016\/j.drugpo.2022.103584","volume":"102","author":"M Karamouzian","year":"2022","unstructured":"Karamouzian M, Pilarinos A, Hayashi K, Buxton JA, Kerr T (2022) Latent patterns of polysubstance use among people who use opioids: a systematic review. Int J Drug Policy 102:103584","journal-title":"Int J Drug Policy"},{"key":"6549_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.drugalcdep.2006.07.009","volume":"87","author":"T Kerr","year":"2007","unstructured":"Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, Wood E (2007) Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend 87:39\u201345","journal-title":"Drug Alcohol Depend"},{"key":"6549_CR31","first-page":"109","volume":"22","author":"RA Kleinknecht","year":"1999","unstructured":"Kleinknecht RA, Kleinknecht EE, Sawchuck CN, Lee T, Lohr JM (1999) Medical fear survey: psychometric properties. Behav Therapist 22:109\u2013119","journal-title":"Behav Therapist"},{"key":"6549_CR32","doi-asserted-by":"publisher","first-page":"103786","DOI":"10.1016\/j.drugpo.2022.103786","volume":"110","author":"N Krawczyk","year":"2022","unstructured":"Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerd\u00e1 M (2022) Has the treatment gap for opioid use disorder narrowed in the U.S.? A yearly assessment from 2010 to 2019. Int J Drug Policy 110:103786","journal-title":"Int J Drug Policy"},{"key":"6549_CR33","doi-asserted-by":"publisher","first-page":"1052113","DOI":"10.3389\/fphar.2022.1052113","volume":"13","author":"CM Laffont","year":"2022","unstructured":"Laffont CM, Ngaimisi E, Gopalakrishnan M, Ivaturi V, Young M, Greenwald MK, Heidbreder C (2022) Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder. Front Pharmacol 13:1052113","journal-title":"Front Pharmacol"},{"key":"6549_CR34","doi-asserted-by":"publisher","first-page":"108334","DOI":"10.1016\/j.drugalcdep.2020.108334","volume":"216","author":"SM Le","year":"2020","unstructured":"Le SM, Trouiller P, Thi HD et al (2020) Daily heroin injection and psychiatric disorders: a cross-sectional survey among people who inject drugs (PWID) in Haiphong, Vietnam. Drug Alcohol Depend 216:108334","journal-title":"Drug Alcohol Depend"},{"key":"6549_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2018.01.007","volume":"87","author":"I Makarenko","year":"2018","unstructured":"Makarenko I, Mazhnaya A, Marcus R et al (2018) Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine. J Subst Abuse Treat 87:1\u20138","journal-title":"J Subst Abuse Treat"},{"key":"6549_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/JCP.0000000000000434","volume":"36","author":"AF Nasser","year":"2016","unstructured":"Nasser AF, Greenwald MK, Vince B, Fudala PJ, Twumasi-Ankrah P, Liu Y, Jones JP III, Heidbreder C (2016) Sustained-release buprenorphine (RBP-6000) blocks the effects of opioid challenge with hydromorphone in subjects with opioid use disorder. J Clin Psychopharmacol 36:18\u201326","journal-title":"J Clin Psychopharmacol"},{"key":"6549_CR37","doi-asserted-by":"publisher","unstructured":"Pahan P, Xie JY (2023 April) 26, online ahead of print) microglial inflammation modulates opioid analgesic tolerance. J Neurosci Res. https:\/\/doi.org\/10.1002\/jnr.25199","DOI":"10.1002\/jnr.25199"},{"key":"6549_CR38","doi-asserted-by":"publisher","first-page":"605","DOI":"10.15288\/jsad.2013.74.605","volume":"74","author":"JS Potter","year":"2013","unstructured":"Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, Martin JA, Ang A, Baker R, Saxon AJ, Ling W (2013) Buprenorphine\/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). J Stud Alcohol Drugs 74:605\u2013613","journal-title":"J Stud Alcohol Drugs"},{"key":"6549_CR39","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1037\/1064-1297.3.4.424","volume":"3","author":"CR Schuster","year":"1995","unstructured":"Schuster CR, Greenwald MK, Johanson CE, Heishman SJ (1995) Measurement of drug craving during naloxone-precipitated withdrawal in methadone-maintained volunteers. Exp Clin Psychopharmacol 3:424\u2013431","journal-title":"Exp Clin Psychopharmacol"},{"key":"6549_CR40","doi-asserted-by":"publisher","first-page":"e32636","DOI":"10.5812\/hepatmon.32636","volume":"16","author":"H Soleimanpour","year":"2016","unstructured":"Soleimanpour H, Safiri S, Nia KS, Sanaie S, Alavian SM (2016) Opioid drugs in patients with liver disease: a systematic review. Hepat Mon 16:e32636","journal-title":"Hepat Mon"},{"key":"6549_CR41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s002130050199","volume":"129","author":"EC Strain","year":"1997","unstructured":"Strain EC, Walsh SL, Preston KL, Liebson IA, Bigelow GE (1997) The effects of buprenorphine in buprenorphine-maintained volunteers. Psychopharmacology 129:329\u2013338","journal-title":"Psychopharmacology"},{"key":"6549_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/105504999305956","volume":"8","author":"J Strang","year":"1999","unstructured":"Strang J, Griffiths P, Powis B, Gossop M (1999) Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. Am J Addict 8:148\u2013160","journal-title":"Am J Addict"},{"key":"6549_CR43","unstructured":"Substance Abuse and Mental Health Services Administration (2021) Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56). Rockville, MD: Center for Behavioral Health Statistics and Quality, SAMHSA. Accessed 28 June 2023 https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt35325\/NSDUHFFRPDFWHTMLFiles2020\/2020NSDUHFFR1PDFW102121.pdf"},{"key":"6549_CR44","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/08897077.2011.630945","volume":"33","author":"Q-L Wang","year":"2012","unstructured":"Wang Q-L, Liu Z-M (2012) Characteristics of psychopathology and the relationship between routes of drug administration and psychiatric symptoms in heroin addicts. Subst Abuse 33:130\u2013137","journal-title":"Subst Abuse"},{"key":"6549_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.drugalcdep.2014.11.016","volume":"146","author":"EA Woodcock","year":"2015","unstructured":"Woodcock EA, Lundahl LH, Greenwald MK (2015) Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteers. Drug Alcohol Depend 146:89\u201396","journal-title":"Drug Alcohol Depend"},{"key":"6549_CR46","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3892\/etm.2021.10437","volume":"22","author":"J Zhou","year":"2021","unstructured":"Zhou J, Ma R, Jin Y, Fang J, Du J, Shao X, Liang Y, Fang J (2021) Molecular mechanisms of opioid tolerance: from opioid receptors to inflammatory mediators. Exp Ther Med 22:1004","journal-title":"Exp Ther Med"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06549-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-024-06549-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06549-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T20:20:44Z","timestamp":1731270044000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-024-06549-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["6549"],"URL":"https:\/\/doi.org\/10.1007\/s00213-024-06549-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]},"assertion":[{"value":"15 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MKG is a consultant for Indivior Inc., which makes buprenorphine products; however, Indivior played no role in this study. The authors declare no conflict of interest with respect to the conduct or content of this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"conflicts of interest"}},{"value":"The contents of the paper are solely the responsibility of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}